TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10545787

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) and leucovorin (LV) administered as a 14-day continuous infusion according to a flat or three different chronomodulated rhythms
Number of subjects: 113

Group type: COMPARATOR
Intervention: 5-fluorouracil (5-FU) and leucovorin (LV)
Number of subjects: 113
Study: 8696436

Group type: EXPERIMENTAL
Intervention: Standard ice bag (group I)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: New cooling blanket (group II)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (contralateral hands)
Number of subjects: 12
Study: 2084084

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 38

Group type: COMPARATOR
Intervention: Uncontrolled Hypertensives
Number of subjects: 38

Group type: COMPARATOR
Intervention: Atenolol vs Captopril
Number of subjects: 38
Study: 320494

Group type: EXPERIMENTAL
Intervention: Dantrium (up to 800 mg for 14‐16 days)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dantrium
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30361957

Group type: EXPERIMENTAL
Intervention: Tamsulosin with cholecalciferol (group-B)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Tamsulosin (group-A)
Number of subjects: 389
Study: 28356030

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Calcium supplementation
Number of subjects: 0
Study: 25974277

Group type: COMPARATOR
Intervention: Control blocks + intravenous (IV) dexamethasone (4 mg)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Control blocks + IV buprenorphine (150 μg) + IV dexamethasone
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Nerve blocks containing buprenorphine + dexamethasone (perineural)
Number of subjects: 90
Study: 23639299

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation practice (3 days a week or more)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mindfulness meditation practice (less than 3 days a week)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation practice (greater number of days meditated)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation practice (minimum of 3 times a week)
Number of subjects: 0
Study: 21324172

Group type: EXPERIMENTAL
Intervention: Web-based intervention (http://www.wiagesprek.nl)
Number of subjects: 123
Study: 19205724

Group type: EXPERIMENTAL
Intervention: Right-handed lifts
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Left-handed lifts
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Lifts at greater distances from the body
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Lifts closer to the body
Number of subjects: 29
Study: 17056258

Group type: EXPERIMENTAL
Intervention: VR environment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Non-VR environment
Number of subjects: 10
Study: 15046282

Group type: EXPERIMENTAL
Intervention: 1 ml 30% glucose
Number of subjects: 57

Group type: COMPARATOR
Intervention: Sterile water
Number of subjects: 57
Study: 11219757

Group type: EXPERIMENTAL
Intervention: Four variants of the subjective workload assessment technique (SWAT) using continuous subscales
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Pairwise comparison procedure
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional SWAT scale
Number of subjects: 15
Study: 9776154

Group type: EXPERIMENTAL
Intervention: Intraoperative irrigation with 10 mL 0.5% bupivacaine in 500 mL saline
Number of subjects: 105

Group type: COMPARATOR
Intervention: Normal saline irrigation
Number of subjects: 105
Study: 7922964

Group type: EXPERIMENTAL
Intervention: Public health nurse intervention promoting safety behaviours
Number of subjects: 68

Group type: COMPARATOR
Intervention: Public health nurse intervention promoting influenza immunization
Number of subjects: 68
Study: 3392652

Group type: EXPERIMENTAL
Intervention: Caffeine (100 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Caffeine (200 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Caffeine (400 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Caffeine (600 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30764710

Group type: EXPERIMENTAL
Intervention: Bringing Baby Home couple‐focused psychoeducational program
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 136
Study: 30591394

Group type: EXPERIMENTAL
Intervention: Bovine bone substitute (Bio-Oss®) in INTER position
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Bovine bone substitute (Bio-Oss®) in ONLAY position
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Autogenous iliac crest bone grafting
Number of subjects: 25
Study: 28988173

Group type: EXPERIMENTAL
Intervention: Topical DPCP therapy for up to 12 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Topical imiquimod therapy for up to 12 months
Number of subjects: 30
Study: 25819865

Group type: EXPERIMENTAL
Intervention: sensitive troponin I (sTnI)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: highly sensitive troponin I (hsTnI)
Number of subjects: 322

Group type: COMPARATOR
Intervention: conventional troponin (cTn)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: hsTnI below limit of detection
Number of subjects: 322
Study: 22820554

Group type: EXPERIMENTAL
Intervention: 200 mg of modafinil
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 21519072

Group type: EXPERIMENTAL
Intervention: Microendoscopic discectomy (MED)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Open discectomy
Number of subjects: 87
Study: 17963038

Group type: EXPERIMENTAL
Intervention: Self-efficacy improvement over time
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Adherence to fat gram goal
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Weight loss after 18 months
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Self-efficacy controlling for fat gram adherence
Number of subjects: 170
Study: 16922749

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (500 mug) prior to anaesthesia and postoperative intravenous patient-controlled analgesia with morphine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Postoperative intravenous patient-controlled analgesia only
Number of subjects: 30
Study: 16145920

Group type: EXPERIMENTAL
Intervention: Ropivacaine with tramadol (Group T)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ropivacaine (Group R)
Number of subjects: 30
Study: 17848760

Group type: EXPERIMENTAL
Intervention: Esmolol (50 microg/kg loading dose followed by 100 microg/kg/hr infusion)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diltiazem (0.15 mg/kg loading dose followed by 5 mg/hr infusion)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diltiazem
Number of subjects: 60
Study: 9354209

Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg once daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Rabeprazole 40 mg once daily
Number of subjects: 20
Study: 8268118

Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl (100 micrograms)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (100 micrograms)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline (control for intravenous fentanyl)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline (control for epidural fentanyl)
Number of subjects: 40
Study: 3899165

Group type: EXPERIMENTAL
Intervention: Topical indomethacin pretreatment
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 31717625

Group type: EXPERIMENTAL
Intervention: Aquatic exercise
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Dry-land exercise
Number of subjects: 37

Group type: COMPARATOR
Intervention: Aquatic control
Number of subjects: 37

Group type: COMPARATOR
Intervention: Dry-land control
Number of subjects: 37
Study: 29359480

Group type: EXPERIMENTAL
Intervention: Fish oil (1000 mg omega-3 fatty acids)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 27590865

Group type: EXPERIMENTAL
Intervention: Yoga intervention (8 weeks of daily sessions)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Best current care (control group)
Number of subjects: 23
Study: 24846347

Group type: EXPERIMENTAL
Intervention: Brodalumab (doses between 140 and 210 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brodalumab
Number of subjects: 0
Study: 22318881

Group type: EXPERIMENTAL
Intervention: Permanent pacemaker implantation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Implantable loop recorder (ILR)
Number of subjects: 120
Study: 20371015

Group type: EXPERIMENTAL
Intervention: Prophylactic ankle brace (Active Ankle Trainer II)
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Prophylactic ankle brace (Aircast Sports Stirrup)
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Non-rigid brace (female players)
Number of subjects: 999

Group type: COMPARATOR
Intervention: Control group (no brace)
Number of subjects: 999
Study: 18076705

Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg subcutaneously once weekly for 12 weeks
Number of subjects: 10
Study: 15969895

Group type: EXPERIMENTAL
Intervention: Nilvadipine 8 mg
Number of subjects: 168

Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 168
Study: 12180075

Group type: EXPERIMENTAL
Intervention: Chorionic villi sampling (CVS)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Genetic amniocentesis (GA)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Hypothetical health states
Number of subjects: 126
Study: 11529652

Group type: EXPERIMENTAL
Intervention: Cisapride 10 mg qid
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 10205348

Group type: EXPERIMENTAL
Intervention: Fortified food and snacks providing an extra 22.2g protein/day and 966 kcal/day
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group ate freely from the hospital menu
Number of subjects: 144
Study: 7955975

Group type: EXPERIMENTAL
Intervention: Acute hypoglycaemia in insulin-dependent diabetic patients
Number of subjects: 22

Group type: COMPARATOR
Intervention: Reference test with normal plasma glucose levels in insulin-dependent diabetic patients
Number of subjects: 22

Group type: COMPARATOR
Intervention: Non-diabetic subjects
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Diabetic patients post-hypoglycaemia
Number of subjects: 22
Study: 3616277

Group type: EXPERIMENTAL
Intervention: Measures taken to handle health problems
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Collaboration with social network
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Contact with professional medical system
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Telephone contacts for health problems in children
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Type of treatment within the family
Number of subjects: 185
Study: 29019449

Group type: EXPERIMENTAL
Intervention: MMA embolization
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 72
Study: 28115015

Group type: EXPERIMENTAL
Intervention: Canakinumab therapy
Number of subjects: 0
Study: 25707487

Group type: EXPERIMENTAL
Intervention: Prolonged-release tacrolimus (0.2mg/kg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prolonged-release tacrolimus (0.15-0.175mg/kg/day) plus basiliximab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prolonged-release tacrolimus (0.2mg/kg/day delayed until Day 5) plus basiliximab
Number of subjects: 0
Study: 24059134

Group type: EXPERIMENTAL
Intervention: Nasopharyngeal airway (group N)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oropharyngeal airway (group O)
Number of subjects: 60
Study: 21733605

Group type: EXPERIMENTAL
Intervention: Oral glutamine supplementation (30g/day, 0.41g/kg/day)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (30g maltodextrin)
Number of subjects: 33
Study: 18654095

Group type: EXPERIMENTAL
Intervention: Second harmonic transthoracic echography with mixture A (dextrose and air)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Second harmonic transthoracic echography with mixture B (dextrose and air and blood)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Second harmonic transthoracic echography with mixture C (hydroxyethylamidon)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Transesophageal echography
Number of subjects: 121
Study: 16583581

Group type: EXPERIMENTAL
Intervention: ECG electrodes
Number of subjects: 390

Group type: COMPARATOR
Intervention: BIS electrodes
Number of subjects: 390
Study: 12774014

Group type: EXPERIMENTAL
Intervention: peginterferon alpha‐2a plus ribavirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: peginterferon alpha‐2a alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: standard interferon alpha‐2b plus ribavirin
Number of subjects: 0
Study: 10831546

Group type: EXPERIMENTAL
Intervention: recombinant FSH (rFSH)
Number of subjects: 91

Group type: COMPARATOR
Intervention: highly purified urinary FSH (uFSH)
Number of subjects: 91
Study: 9356548

Group type: EXPERIMENTAL
Intervention: Dairy product-free diet
Number of subjects: 18

Group type: COMPARATOR
Intervention: Dairy product-rich diet
Number of subjects: 18
Study: 8412294

Group type: EXPERIMENTAL
Intervention: Complete Remission (CR) in patients treated for advanced Hodgkin's disease
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Overall Survival
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Disease-Free Survival
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Response Rate to Radiation Therapy in young cohort
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Salvage Therapy Response Rate
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Survival after Relapse
Number of subjects: 560
Study: 31135580

Group type: EXPERIMENTAL
Intervention: Visual aids during consent process
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 64
Study: 30704298

Group type: EXPERIMENTAL
Intervention: TAVR using the self‐expanding CoreValve prosthesis
Number of subjects: 280

Group type: COMPARATOR
Intervention: SAVR using any stented bioprostheses
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 280

Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 280
Study: 28403471

Group type: EXPERIMENTAL
Intervention: STARTS intervention (specialized focus on mood, weight, and stress)
Number of subjects: 300

Group type: COMPARATOR
Intervention: SUPPORT intervention (comparison group)
Number of subjects: 300

Group type: COMPARATOR
Intervention: SUPPORT intervention
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: STARTS intervention
Number of subjects: 300
Study: 25111040

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 24023022

Group type: EXPERIMENTAL
Intervention: Group F (full spinal flexion)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Group N (hips and back straightened)
Number of subjects: 32
Study: 21311355

Group type: EXPERIMENTAL
Intervention: l-Arg HCl (30 g at 0.5 g·min(‐1))
Number of subjects: 7

Group type: COMPARATOR
Intervention: Saline (Control, CON)
Number of subjects: 7
Study: 18294115

Group type: EXPERIMENTAL
Intervention: Anticholinergic therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of anticholinergic therapy with alpha1‐antagonists
Number of subjects: 0
Study: 17133492

Group type: EXPERIMENTAL
Intervention: IFN-alpha (3 million units 3 times every week for 48 weeks)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control
Number of subjects: 150
Study: 14972218

Group type: EXPERIMENTAL
Intervention: Radio frequency fistulotomy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional fistulotomy
Number of subjects: 100
Study: 10632419

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC) for the first two cycles and human menopausal gonadotropin (hMG) for the last two cycles (CCHH)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Human menopausal gonadotropin (hMG) for the first two cycles and clomiphene citrate (CC) for the last two cycles (HHCC)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Human menopausal gonadotropin (hMG)
Number of subjects: 58
Study: 8923572

Group type: EXPERIMENTAL
Intervention: 0.56 g/kg alcohol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: COMPARATOR
Intervention: No beverage
Number of subjects: 60
Study: 1396075

Group type: EXPERIMENTAL
Intervention: ondansetron
Number of subjects: 52

Group type: COMPARATOR
Intervention: routine anti-emetic regimen
Number of subjects: 52
Study: 3986473

Group type: EXPERIMENTAL
Intervention: Cefuroxime (Group I)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Cefuroxime plus metronidazole (Group II)
Number of subjects: 122
Study: 27442606

Group type: EXPERIMENTAL
Intervention: Parent And Caregiver Active Participation Toolkit
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 20
Study: 27112041

Group type: EXPERIMENTAL
Intervention: Early fortification (EF) starting at 20 mL/kg/d
Number of subjects: 100

Group type: COMPARATOR
Intervention: Delayed fortification starting at 100 mL/kg/d
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Early fortification (EF)
Number of subjects: 100
Study: 23911705

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 227

Group type: COMPARATOR
Intervention: Best available therapy
Number of subjects: 227
Study: 22507335

Group type: EXPERIMENTAL
Intervention: Loratadine syrup
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cyproheptadine HCl solution
Number of subjects: 60
Study: 20103550

Group type: EXPERIMENTAL
Intervention: Intensive glycemia treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard glycemia treatment
Number of subjects: 0
Study: 17087620

Group type: EXPERIMENTAL
Intervention: Lifestyle Change (LC)
Number of subjects: 508

Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 508
Study: 14687172

Group type: EXPERIMENTAL
Intervention: Atrophic gastritis
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Low vitamin B12
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (non-atrophic gastritis)
Number of subjects: 31
Study: 11368128

Group type: EXPERIMENTAL
Intervention: Vulvar pain group
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 79
Study: 9273182

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (ICT) including three cycles of 5-fluorouracil (600 mg/m2/d), cisplatin (15 mg/m2/d), etoposide (50 mg/m2/d), hydroxyurea (1,500 mg/d)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Concomitant chemotherapy and chest radiotherapy (CCRT) with cisplatin (20 mg/m2) and 5-fluorouracil (500 mg/m2) during radiotherapy
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Responders to ICT
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Non-responders to ICT
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 46
Study: 8077090

Group type: EXPERIMENTAL
Intervention: Lysine clonixinate (125 mg, 1 or 2 tablets every 8 h for 48 h)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Paracetamol (500 mg, 1 or 2 tablets every 8 h for 48 h)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 200
Study: 3438782

Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2a (6 X 10(6) or 18 X 10(6) units)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2a
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 31256650

Group type: EXPERIMENTAL
Intervention: 1 g of intravenous (IV) TXA given prior to the skin incision
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Double-dose regimen of 1 g IV TXA given prior to skin incision and at time of wound closure
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Combination of 1 g IV TXA given prior to skin incision and 1 g of intraoperative topical TXA
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Three doses of 1950 mg oral TXA given two hours preoperatively, six hours postoperatively, and on the morning of postoperative day one
Number of subjects: 186

Group type: COMPARATOR
Intervention: All TXA regimens tested
Number of subjects: 186
Study: 28944355

Group type: EXPERIMENTAL
Intervention: Immediate placement of 6.0 to 8.0 mm wide diameter implants (immediate group; 50 patients)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Delayed placement of 4.0 or 5.0 mm diameter implants (delayed group; 50 patients)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Immediate group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Delayed group
Number of subjects: 100
Study: 26613263

Group type: EXPERIMENTAL
Intervention: Exposure and response prevention (EX/RP)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 32
Study: 24382338

Group type: EXPERIMENTAL
Intervention: CoA 400 U/d plus statin
Number of subjects: 304

Group type: COMPARATOR
Intervention: Placebo plus statin
Number of subjects: 304
Study: 22591717

Group type: EXPERIMENTAL
Intervention: Suture-less technique
Number of subjects: 80

Group type: COMPARATOR
Intervention: Multiple sutures
Number of subjects: 80
Study: 19772499

Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no atorvastatin)
Number of subjects: 50
Study: 17404896

Group type: EXPERIMENTAL
Intervention: Oral bovine collagen
Number of subjects: 275

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Change in SF‐36 item
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: HAQ‐DI and skin score as anchors
Number of subjects: 275
Study: 15680822

Group type: EXPERIMENTAL
Intervention: Minimally invasive port access mitral valve surgery (group I)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional mitral valve surgery (group II)
Number of subjects: 40
Study: 12101535

Group type: EXPERIMENTAL
Intervention: Noncontrast helical computed tomography (NHCT)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Intravenous pyelography
Number of subjects: 119